These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32329833)
1. Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer. Zhang Z; Li JZ; Wei ZW; Li F; Li HM; Xiao Y; Qin YQ Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3586-3591. PubMed ID: 32329833 [TBL] [Abstract][Full Text] [Related]
2. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Li X; Wu Y; Liu A; Tang X Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141 [TBL] [Abstract][Full Text] [Related]
5. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933 [TBL] [Abstract][Full Text] [Related]
6. Loss of lncRNA UCA1 ameliorates the injury managed by cerebral ischemia-reperfusion by sponging miR-18a-5p. Yan J; Gao Y; Huang J; Gao W; Li Y; Lin B Folia Neuropathol; 2023; 61(1):77-87. PubMed ID: 37114963 [TBL] [Abstract][Full Text] [Related]
7. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Zhu HY; Bai WD; Ye XM; Yang AG; Jia LT Biochem Biophys Res Commun; 2018 Feb; 496(4):1308-1313. PubMed ID: 29408336 [TBL] [Abstract][Full Text] [Related]
10. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Yao J; Fu J; Liu Y; Qu W; Wang G; Yan Z Ann Hepatol; 2021; 23():100297. PubMed ID: 33346094 [TBL] [Abstract][Full Text] [Related]
11. [Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a]. Li XN; Liu AH; Tang X; Ren Y Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):295-302. PubMed ID: 28416841 [TBL] [Abstract][Full Text] [Related]
12. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer. Sun L; Liu L; Yang J; Li H; Zhang C J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10. Wang X; Lu J; Cao J; Ma B; Gao C; Qi F Onco Targets Ther; 2018; 11():7919-7934. PubMed ID: 30519035 [TBL] [Abstract][Full Text] [Related]
14. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation. Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726 [TBL] [Abstract][Full Text] [Related]
15. Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance. Yun JH; Baek MJ; Jung HI Korean J Clin Oncol; 2022 Jun; 18(1):17-26. PubMed ID: 36945332 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521 [TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
20. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]